Edition:
United Kingdom

ContraFect Corp (CFRX.OQ)

CFRX.OQ on NASDAQ Stock Exchange Capital Market

1.99USD
16 Aug 2018
Change (% chg)

$0.01 (+0.51%)
Prev Close
$1.98
Open
$2.01
Day's High
$2.07
Day's Low
$1.97
Volume
11,355
Avg. Vol
27,668
52-wk High
$2.90
52-wk Low
$0.80

Chart for

About

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin... (more)

Overall

Beta: --
Market Cap(Mil.): $95.02
Shares Outstanding(Mil.): 73.66
Dividend: --
Yield (%): --

Financials

  CFRX.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.49 -- --
ROI: -104.45 1.78 14.61
ROE: -153.83 3.28 16.33

BRIEF-ContraFect Announces Q1 Loss Per Share $0.26

* CONTRAFECT - AS OF MARCH 31, 2018, HAD CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $39.9 MILLION, COMPARED TO $46.9 MILLION AS OF DECEMBER 31, 2017

10 May 2018

Earnings vs. Estimates